Pharming’s Public Offer to Abliva

Vinge advised Abliva on the deal. Pharming Technologies B.V., a wholly owned subsidiary of Pharming Group N.V., has announced a public offer to the shareholders of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Pricer AB’s Bonds Offering

Vinge advised Pricer AB on the deal. Pricer AB (publ) completed its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Carasent’s Listing on Nasdaq Stockholm

Vinge advised Carasent on the deal. Carasent AB (publ) completed the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Xspray Pharma’s Rights Offering

Vinge advised Xspray Pharma on the deal. Xspray Pharma AB (publ) completed a rights issue of shares whereby Xspray receives issue proceeds of approximately SEK 135...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here